Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Catamaran Corporation
Type
Public
Traded as TSX: CCT
NASDAQ: CTRX
S&P/TSX 60 component
NASDAQ-100 Component
Industry PBM and Health informatics
Predecessor SXC Health Solutions
Founded 2013
Headquarters Schaumburg, Illinois, United States
Key people
Terrece C Burke, Chair
Mark A Thierer, President, Chief EXEC
Revenue $14,780.094 milIncrease49% 2013
Net income
$287.739 milIncrease138% 2013
Total assets $7,995.763 milIncrease8% 2013
Total equity $4,908.490 milIncrease6% 2013
Number of employees
4,000 (Dec 31, 2013)
1,433 (Dec.31,2011)
1,216 (Feb.25,2011)
Divisions informedRx
Healthcare IT Group
HBS Health Business Systems
Website www.catamaranrx.com

Catamaran Corporation (formerly SXC Health Solutions) is a Schaumburg, Illinois based pharmacy benefit management company that sells services related to pharmacy benefit management and medical record keeping to businesses in the United States. Working independently of the government and insurance companies allows it to operate as a third party verifier; the RxCLAIM online claim processing system allows for prescription drug claims to be processed online if the customer lives in and fills his/her prescription in the United States. The system has no way of accommodating customers who live/work in foreign countries but have health care/prescription drug insurance through a retirement system such as the Michigan Public School Employees Retirement System. SXC has three separate but interrelated business segments which deal with prescription drug programs. For 2013 23% of company revenue came from Cigna Corporation.

Investment goal date:
Dividends reinvested
Catamaran Corporation CTRX report Q1 2015
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q3 2015
2015-11-02
--
--
Q2 2015
2015-07-30
--
--
Q1 2015
2015-04-30
0.5900
0.4200
Q4 2014
2015-02-26
0.6700
0.4800
Q3 2014
2014-10-30
0.5800
0.3900
Q2 2014
2014-08-01
0.5400
0.3400
Q1 2014
2014-05-01
0.5000
0.3100
Q4 2013
2014-02-27
0.5600
0.3600
Q3 2013
2013-10-31
0.5200
0.3500
Q2 2013
2013-08-01
0.4900
0.3100
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Adamant Biomedical Investments AG
206820
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
140
NEW ENGLAND SECURITIES CORP /MA/
280
Placemark Investments, Inc.
65441
SpiderRock Trading LLC
559
Major Shareholders
Name Relationship
Total Shares
Holding stocks
Thorne Curtis
0.0100% (13850)
CTRX /
% ()